PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide:: First results in patients with meningiomas

被引:0
|
作者
Henze, M
Schuhmacher, J
Hipp, P
Kowalski, J
Becker, DW
Doll, J
Mäcke, HR
Hofmann, M
Debus, J
Haberkorn, U
机构
[1] Univ Heidelberg, Dept Nucl Med, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, D-6900 Heidelberg, Germany
[3] Univ Basel Hosp, CH-4031 Basel, Switzerland
[4] Hannover Med Sch, D-3000 Hannover, Germany
关键词
somatostatin receptors; DOTATOC; Ga-68; PET; meningioma;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Imaging of somatostatin receptors (SSTRs) using [In-111]diethylenetriaminepentaacetic-acid-octreotide (DTPAOC) has proven to be helpful in the differentiation of meningiomas, neurinomas or neurofibromas, and metastases as well as in the follow-up of meningiomas, A drawback of the SPECT method is its limited sensitivity in detecting small meningiomas. Because of PET's increased spatial resolution and its ability to absolutely quantify biodistribution, a PET tracer for SSTR imaging would be desirable. Methods: 1,4,7,10-tetraazacyclododecane-N,N ' ,N "N ' ' ' -tetraacetic-acid-D-Phe(1)-Tyr(3)-octreotide (DOTATOC) was labeled using the positron-emitting generator nuclide Ga-68. We acquired dynamic PET images over 120 min after intravenous injection of 175 MBq [Ga-68]DOTATOC in 3 patients suffering from 8 meningiomas (WHO I-o; 7- to 25-mm diameter). Patients' heads had been fixed using individually shaped fiber masks equipped with an external stereotactic localizer system to match PET, CT, and MRI datasets. Results: [68Ga]DOTATOC was rapidly cleared from the blood (half-life alpha, 3.5 min; half-life beta, 63 min). Standardized uptake values (SUVs) of meningiomas increased immediately after injection and reached a plateau 60-120 min after injection (mean SUV, 10.6). No tracer could be found in the surrounding healthy brain tissue. AH meningiomas (even the 3 smallest [7- to 8-mm diameter]) showed high tracer uptake and could be visualized clearly. Tracer boundaries showed a good correspondence with the matched CT and MRI images. PET provided valuable additional information regarding the extent of meningiomas located beneath osseous structures, especially at the base of the skull. Conclusion: According to our initial experiences, [Ga-68]DOTATOC seems to be a very promising new PET tracer for imaging SSTRs even in small meningiomas, offering excellent imaging properties and a very high tumor-to-background ratio.
引用
收藏
页码:1053 / 1056
页数:4
相关论文
共 15 条
  • [1] Characterization of 68Ga-DOTA-D-Phe1-Tyr3- octreotide kinetics in patients with meningiomas
    Henze, M
    Dimitrakopoulou-Strauss, A
    Milker-Zabel, S
    Schuhmacher, J
    Strauss, LG
    Doll, J
    Mäcke, HR
    Eisenhut, M
    Debus, J
    Haberkorn, U
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (05) : 763 - 769
  • [2] Evaluation of 64Cu-labeled DOTA-d-Phe1-Tyr3-octreotide (64Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors
    Hanaoka, Hirofumi
    Tominaga, Hideyuki
    Yamada, Keiich
    Paudyal, Pramila
    Iida, Yasuhiko
    Watanabe, Shigeki
    Paudyal, Bishnuhari
    Higuchi, Tetsuya
    Oriuchi, Noboru
    Endo, Keigo
    ANNALS OF NUCLEAR MEDICINE, 2009, 23 (06) : 559 - 567
  • [3] 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT
    Gabriel, Michael
    Decristoforo, Clemens
    Kendler, Dorota
    Dobrozemsky, Georg
    Heute, Dirk
    Uprimny, Christian
    Kovacs, Peter
    Von Guggenberg, Elisabeth
    Bale, Reto
    Virgolini, Irene J.
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 : 189S - 198S
  • [4] 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and CT
    Gabriel, Michael
    Decristoforo, Clemens
    Kendler, Dorota
    Dobrozemsky, Georg
    Heute, Dirk
    Uprimny, Christian
    Kovacs, Peter
    Von Guggenberg, Elisabeth
    Bale, Reto
    Virgolini, Irene J.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) : 508 - 518
  • [5] 68Ga-DOTA-Tyr3-Octreotide PET for Assessing Response to Somatostatin-Receptor-Mediated Radionuclide Therapy
    Gabriel, Michael
    Oberauer, Andreas
    Dobrozemsky, Georg
    Decristoforo, Clemens
    Putzer, Daniel
    Kendler, Dorota
    Uprimny, Christian
    Kovacs, Peter
    Bale, Reto
    Virgolini, Irene J.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (09) : 1427 - 1434
  • [6] Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy
    Putzer, Daniel
    Gabriel, Michael
    Henninger, Benjamin
    Kendler, Dorota
    Uprimny, Christian
    Dobrozemsky, Georg
    Decristoforo, Clemens
    Bale, Reto Josef
    Jaschke, Werner
    Virgolini, Irene Johanna
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (08) : 1214 - 1221
  • [7] Quantification in 68Ga-DOTA(0)-Phe(1)-Tyr(3)-Octreotide Positron Emission Tomography/Computed Tomography: Can We Be Impartial about Partial Volume Effects?
    Ruf, Juri
    Schiefer, Jan
    Kropf, Siegfried
    Furth, Christian
    Ulrich, Gerhard
    Kosiek, Ortrud
    Denecke, Timm
    Pavel, Marianne
    Pascher, Andreas
    Wiedenmann, Bertram
    Amthauer, Holger
    NEUROENDOCRINOLOGY, 2013, 97 (04) : 369 - 374
  • [8] [18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients
    Pauwels, Elin
    Cleeren, Frederik
    Tshibangu, Terence
    Koole, Michel
    Serdons, Kim
    Dekervel, Jeroen
    Van Cutsem, Eric
    Verslype, Chris
    Van Laere, Koen
    Bormans, Guy
    Deroose, Christophe M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (13) : 3033 - 3046
  • [9] [18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients
    Elin Pauwels
    Frederik Cleeren
    Térence Tshibangu
    Michel Koole
    Kim Serdons
    Jeroen Dekervel
    Eric Van Cutsem
    Chris Verslype
    Koen Van Laere
    Guy Bormans
    Christophe M. Deroose
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 3033 - 3046
  • [10] Al18F-NOTA-Octreotide PET Imaging of the Somatostatin Receptor: First Comparison with 68Ga-DOTATATE in Neuroendocrine Tumor Patients
    Pauwels, E.
    Cleeren, F.
    Tshibangu, T.
    Koole, M.
    Serdons, K.
    Dekervel, J.
    Van Cutsem, E.
    Verslype, C.
    Van Laere, K.
    Bormans, G.
    Deroose, C. M.
    NEUROENDOCRINOLOGY, 2020, 110 : 269 - 269